US Executive Officer Management Changes SEC — July 01, 2026

01-07-2026

Provectus Biopharmaceuticals will convert $542,500 of accrued but unpaid directors' fees into Series D-1 Preferred Stock at $2.862 per share, issuing 189,554 preferred shares (convertible into 1,895,540 common shares) to satisfy outstanding cash compensation owed to board members through June 30, 2026. The conversion, approved on May 14, 2026, is not part of the company's 2024 Equity Compensation Plan and addresses fees that had been accruing since April 2017.

• · The conversion was approved by the Board on May 14, 2026.
• · Directors' fees had been accruing since April 12, 2017, when the Board approved deferring payment.
• · The preferred stock issuance is not part of the company's 2024 Equity Compensation Plan.

01-07-2026

Dynatrace appointed George Riedel and Dan Streetman to its Board of Directors following constructive engagement with activist investor Starboard Value. The company also announced plans to hold an Investor Day after its Q2 fiscal 2027 results to outline a path to the 'Rule of 50' by fiscal 2029, while reiterating its $1 billion share repurchase authorization. The appointments and strategic focus aim to drive balanced growth and profitability, though no specific financial results or timelines for capital return were provided.

• · George Riedel brings experience as CEO/Chairman at Cloudmark, Chief Strategy Officer at Nortel Networks, and Senior Partner at McKinsey.
• · Dan Streetman is CEO of Tanium and previously CEO of TIBCO Software; he also held senior roles at BMC, Salesforce, and C3.ai.
• · Dynatrace and Starboard intend to engage substantively in the coming months.
• · The Investor Day will follow the announcement of Q2 fiscal 2027 financial results.
• · Rule of 50 defined as sum of ARR growth rate and non-GAAP operating margin percentage.

01-07-2026

Nova Minerals appointed Joshua Girnun, a former JP Morgan metals & mining professional, to its Board of Directors effective July 1, 2026. The company is advancing its Estelle Gold and Critical Minerals Project and preparing for near-term antimony production backed by a $43.4 million U.S. Department of War award. The appointment comes after the company's redomiciliation from Australia to the U.S., aiming to improve access to capital and index inclusion.

• · Mr. Girnun co-founded a risk underwriting team at JP Morgan covering metals, mining, energy, renewables, industrials, oil & gas, and agriculture.
• · He holds a Master of Science in Metals and Energy Finance from Imperial College London and a Master of Science in Geosciences from Hebrew University of Jerusalem.
• · Estelle hosts two defined multi-million-ounce gold resources and more than 20 prospects along a 35 km trend.
• · The antimony production is targeted for late 2026/2027.
• · Mr. Girnun's research has been published in the Journal of Structural Geology.

01-07-2026

BTCS Inc. appointed Chris Janis to its Board of Directors as Chairperson of the Audit Committee and a member of the Compensation Committee, effective July 1, 2026. Mr. Janis brings over 35 years of experience, including as a Partner at PwC's Cyber, Risk & Regulatory Practice until his retirement in June 2026, and prior CFO roles in telecom and tech. The appointment strengthens the Company's governance and financial oversight as it advances its blockchain infrastructure and DeFi/TradFi strategy.

• · Mr. Janis served as a Partner at PwC from 2015 to June 2026, leading internal audit engagements focused on risk management and internal controls.
• · Prior to PwC, he served as CFO in the telecommunications and technology sectors, guiding companies through M&A, financings, and restructurings.
• · Mr. Janis holds an MBA from Saint Joseph's University and a BS in Accounting and Finance from La Salle University.
• · BTCS is an Ethereum-first blockchain technology company with operations in NodeOps (staking), Builder+ (block building), and Imperium (DeFi deployments).

01-07-2026

Tortoise Energy Infrastructure Corporation (TYG) announced the resignation of director Alexandra Herger effective July 1, 2026, and the appointment of John Maxwell to succeed her on the Board and the Nominating and Governance Committee. Mr. Maxwell, a retired portfolio manager with a CFA designation, has been nominated for a full 3-year term as a Class I director at the 2026 Annual Meeting. The change is a routine board succession with no disclosed material relationships or transactions.

• · John Maxwell previously served as Lead Portfolio Manager at Delaware Ivy Investments/Waddell & Reed/Ivy Investments from 2006 to 2021.
• · Mr. Maxwell holds the Chartered Financial Analyst (CFA) designation since 1998.
• · He also serves as an independent trustee for Tortoise Capital Series Trust.
• · Mr. Maxwell will be compensated per the 2025 director compensation elements described in the company's proxy statement filed July 10, 2025.

01-07-2026

National Bankshares, Inc. entered into a consulting agreement with Chairman F. Brad Denardo effective July 1, 2026 to June 30, 2027, extending a prior agreement. Mr. Denardo will receive a monthly fee of $6,000 and is subject to noncompetition covenants. The agreement continues his advisory role after his departure as President and CEO.

• · Consulting agreement extends a prior agreement dated March 31, 2025.
• · Consulting period is from July 1, 2026 to June 30, 2027, with possible extension by mutual agreement.
• · Mr. Denardo is subject to customary noncompetition covenants during the consulting period.
• · The agreement will be filed as an exhibit to the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2026.

01-07-2026

IREN Ltd granted 9,099,328 RSUs to each of its Co-CEOs, William Roberts and Daniel Roberts, on June 30, 2026. The awards vest over four years with an additional two-year post-vesting holding period, and neither Co-CEO will receive further equity grants until fiscal 2031. The grants are designed to retain leadership and align interests with long-term shareholder value, but represent a significant dilution event with no immediate performance-based vesting conditions.

• · The RSUs vest in equal annual installments over four years from the grant date, subject to continued employment.
• · Each vested tranche is subject to an additional two-year post-vesting holding period, extending to fiscal 2033 for the final tranche.
• · The grants were unanimously approved by independent directors after consultation with an independent compensation consultant.
• · The Compensation Committee considered alternative structures including different grant sizes, performance-based and hybrid structures, and alternative vesting periods before selecting the approved structure.
• · The awards are granted under the IREN Limited 2025 Omnibus Incentive Plan.

01-07-2026

Velo3D granted CEO Arun Jeldi a performance-based stock option for 964,474 shares at $18.40, vesting only if market capitalization milestones ($1B, $3B, $5B, $10B) are achieved within five years. The company also entered Change in Control Agreements with the CEO, CFO, and Chief Revenue Officer, providing severance benefits including salary, bonus, equity acceleration, and medical coverage upon qualifying termination around a change in control. The awards are highly contingent on significant market cap growth and do not reflect any current financial performance changes.

• · The performance-based option was granted under the company's 2021 Equity Incentive Plan.
• · Vesting milestones must be achieved within five years from the grant date.
• · Once vested, the option remains exercisable until the earlier of the 10th anniversary of the grant date or one year after cessation of service.
• · CIC Agreements cover termination without cause or resignation for good reason within a period starting three months before and ending twelve months after a change in control.
• · Severance benefits include a lump sum of base salary plus target annual bonus plus pro-rata target bonus, vesting of time-based equity, and 12 months of medical premium coverage.
• · Benefits are subject to a general release of claims and may be reduced to avoid golden parachute excise tax if it results in a higher net after-tax amount for the executive.

01-07-2026

Scotts Miracle-Gro announced a strategic leadership succession, appointing Nate Baxter as President and CEO effective immediately, and Pete Shumlin as Chairman of the Board. Jim Hagedorn, CEO since 2001, transitions out as part of a long-term internal plan. The company reaffirmed its Fiscal 2026 guidance, projecting low single-digit U.S. Consumer net sales growth, non-GAAP adjusted EBITDA mid single-digit growth, and free cash flow of approximately $275 million, but also noted a leverage ratio in the high 3's, indicating ongoing debt reduction needs.

• · Nate Baxter joined the company in April 2023 as EVP, technology and operations, became COO in September 2023, and president and COO in 2024.
• · Jim Hagedorn led the merger of Miracle-Gro with The Scotts Company in 1995 and the public listing of SMG on the NYSE.
• · The company will host its 2026 Investor Day at the New York Stock Exchange on August 4, 2026.
• · Baxter is a general partner of the Hagedorn Partnership, L.P., the largest shareholder of the company.
• · Non-GAAP adjusted EBITDA mid single-digit growth is part of the fiscal 2026 guidance.

01-07-2026

Employers Holdings, Inc. (NYSE:EIG) announced the appointment of Stephanie C. Bush to its Board of Directors, effective July 1, 2026. Ms. Bush brings over 30 years of experience in underwriting, product management, and distribution from The Hartford and Travelers, and currently serves on multiple insurance and advisory boards. The appointment strengthens the board's expertise in small commercial lines and industry leadership.

• · Ms. Bush retired from The Hartford in March 2024 after serving as EVP and Head of Small Commercial and Personal Lines Insurance.
• · She previously led Travelers Personal Insurance Product Management as SVP from 2008 to 2012.
• · She holds a BA in political science from the University of Missouri–St. Louis.
• · Employers' insurance subsidiaries are rated A (Excellent) by AM Best.

01-07-2026

Zumiez Inc. announced on June 30, 2026, that CFO Christopher C. Work is stepping down after 19 years of service. He will remain in his role until a successor is found, and the company has engaged an executive search firm. The filing does not disclose any financial metrics or performance data.

• · CFO Christopher C. Work gave notice of resignation on June 30, 2026.
• · He will continue as CFO and assist with transition until a successor is appointed.
• · The company has engaged a leading executive search firm to find a new CFO.

01-07-2026

At its 2026 Annual Meeting on June 30, Petco stockholders approved a Plan Amendment to increase shares reserved under the 2021 Equity Incentive Plan by 15.5 million shares. All four director nominees were elected, the say-on-pay proposal passed, and Ernst & Young LLP was ratified as auditor for FY2027. Approximately 24 million broker non-votes were recorded on three of four proposals, indicating modest retail participation on those items.

• · Say-on-pay (Proposal 2) received 201,860,152 votes for, 42,922,182 against, and 1,564,386 abstentions.
• · Ratification of Ernst & Young (Proposal 4) passed overwhelmingly: 269,971,930 for, 343,606 against, 123,776 abstentions, and no broker non-votes.
• · All director nominees were elected with votes for ranging from 200.9 million (Nishad Chande) to 215.0 million (Joel Anderson).
• · Broker non-votes totaled approximately 24.1 million on Proposals 1, 2, and 3.

01-07-2026

Box Inc. held its annual meeting on June 25, 2026, where stockholders approved an amendment to the 2015 Equity Incentive Plan, increasing the share reserve by 7.2 million shares. The meeting also saw the election of three Class III directors (Sue Barsamian, Jack Lazar, Steve Murphy) and advisory approval of executive compensation. However, the equity plan amendment passed with a relatively narrow margin (75.0 million for vs. 47.0 million against), and director Sue Barsamian received a significant 40.4 million against votes, indicating notable shareholder dissent.

• · Proposal 4 (ratification of Ernst & Young as auditor) passed overwhelmingly: 125.8 million for, 4.4 million against.
• · Proposal 2 (advisory vote on executive compensation) passed with 120.7 million for, 1.3 million against.
• · Proposal 3 (equity plan amendment) had a narrower approval: 75.0 million for, 47.0 million against.
• · Director Sue Barsamian received 40.4 million against votes, the highest dissent among the three nominees.
• · The record date for voting was May 1, 2026.

01-07-2026

Mativ Holdings, Inc. appointed Bruce Hausmann, CFO of Interface, Inc., to its Board of Directors effective July 1, 2026, where he will serve on the Audit Committee. Hausmann brings over 25 years of corporate and operational finance experience across multiple industries and capital structures. The appointment strengthens the Board's financial expertise as the company executes its strategic priorities, though no specific financial metrics or performance data were disclosed in the filing.

• · Hausmann will serve on the Company's Audit Committee.
• · He has been Vice President and CFO of Interface, Inc. since April 2017.
• · Hausmann holds a Bachelor of Science in Finance from Arizona State University and is a Certified Public Accountant (Inactive).
• · Mativ operates two segments: Filtration & Advanced Materials and Sustainable & Adhesive Solutions.
• · The company manufactures on three continents and generates sales in over 80 countries.

01-07-2026

AppFolio announced the retirement of directors Andreas von Blottnitz and Janet Kerr, effective June 29, 2026, and the election of Diya Jolly and Michael Yang as new Class I directors. Shane Trigg was appointed Chairman of the Board, and Winifred Webb as Lead Independent Director. The non-employee director compensation was updated: committee chair retainers decreased from $50,000 to $40,000, annual equity awards increased from $150,000 to $200,000, and a new $40,000 retainer for the Lead Independent Director was introduced.

• · Andreas von Blottnitz served as director since 2007; Janet Kerr since 2015.
• · Retirements not due to any disagreement with the Company.
• · New directors Diya Jolly and Michael Yang are independent under Nasdaq and SEC rules.
• · Diya Jolly is Chief Product and Technology Officer of Xero Limited; previously CPO at Okta, product roles at Google, FreeWheel, Microsoft, and business analyst at McKinsey.
• · Michael Yang is a Partner at Investment Group of Santa Barbara and Founder/CEO of Toro TMS; previously at McKinsey, U.S. Steel, Tiger Management.
• · Shane Trigg will not receive separate compensation for Chairman role.
• · Committee assignments: Saori Casey to Audit Committee; Casey and Yang to Compensation Committee; Yang to Nominating and Corporate Governance Committee; Jolly to Risk and Compliance Oversight Committee.

01-07-2026

Climb Bio, Inc. (CLYM) announced the resignation of director Andrew Levin effective June 29, 2026, and the immediate election of Breanna O'Reilly, Ph.D. as a new director. Dr. O'Reilly will serve until the 2027 annual meeting and received an option to purchase 70,284 shares at $13.36 per share, vesting over three years, plus an annual cash retainer of $40,000.

• · Dr. O'Reilly's option vests in equal monthly installments from June 29, 2026 until the third anniversary of the Vesting Commencement Date, subject to continued service.
• · Dr. O'Reilly has no family relationships with any directors or executive officers and no related-party transactions requiring disclosure under Item 404(a).
• · Dr. O'Reilly entered into an indemnification agreement with the company, the form of which was previously filed as Exhibit 10.8 to the Company's S-1 registration statement.

01-07-2026

Astrana Health, Inc. announced that Glenn Sobotka will retire as Chief Accounting Officer and principal accounting officer effective August 7, 2026, with John Vong succeeding him in that role. John Vong's annual base salary was increased to $320,000 effective July 1, 2026, while his target bonus opportunity for 2026 remains unchanged. The retirement is not due to any disagreement with the company.

• · John Vong previously served as Astrana's Chief Accounting Officer from November 2022 to March 2025 and as Vice President of Finance and Accounting from July 2022 to November 2022.
• · John Vong began his career as a certified public accountant with RSM.
• · John Vong holds a Bachelor of Science in Business Administration from the University of California, Riverside and an MBA from the University of California, Irvine.
• · No family relationships exist between John Vong and any of Astrana's directors or executive officers.

01-07-2026

National Health Investors, Inc. (NHI) entered into a Change in Control Severance Agreement with CFO Todd Siefert on July 1, 2026. The agreement provides for severance benefits including a lump sum cash payment equal to 2.0 times the average of the Executive's annual base salary and bonus for the most recent two consecutive calendar years, accelerated equity vesting, and 18 months of COBRA coverage, contingent upon a qualifying termination within two years following a Change in Control. The agreement also includes non-competition and non-solicitation restrictions for 12 months after severance benefits become payable.

• · The CIC Severance Agreement is effective as of July 1, 2026.
• · Severance is in lieu of any severance under any other agreement or arrangement.
• · Qualifying termination includes termination by the Company without Cause or by the Executive for Good Reason within two years following a Change in Control, or termination without Cause within 30 days prior to a Change in Control.
• · The lump sum cash payment is 2.0 times the average of the Executive's annual base salary and bonus for the most recent two consecutive calendar years.
• · A pro-rated annual bonus payment is also provided, equal to the greater of target bonus or earned bonus based on performance through termination.
• · Accelerated vesting applies only to equity awards subject solely to time-based vesting.
• · The agreement includes a 'best net' cutback provision for excise tax under Section 4999 of the Code.
• · Non-competition and non-solicitation restrictions apply during employment and for 12 months after severance benefits are payable.
• · Confidentiality restrictions apply during and after employment.

01-07-2026

Columbus McKinnon announced the appointment of John R. Linker as EVP of Finance and CFO, effective July 1, 2026, succeeding Gregory P. Rustowicz. The company also reaffirmed its fiscal year 2027 guidance as previously announced on June 4, 2026. No financial figures or performance metrics were disclosed in this filing.

• · John R. Linker previously served as CFO of Husky Technologies Limited, where he improved financial flexibility and drove record earnings growth.
• · Linker also served as CFO and COO of Serta Simmons Bedding LLC, leading a commercial and operational turnaround that drove substantial margin improvement.
• · Prior roles include CFO at JELD-WEN Holding, Inc., where he oversaw initiatives leading to significant earnings growth and the company's successful IPO in 2017.
• · Gregory P. Rustowicz is departing after 15 years with the company.
• · The company reaffirmed its fiscal year 2027 guidance, originally issued on June 4, 2026.

01-07-2026

X4 Pharmaceuticals appointed Kelly Gold, an experienced CFO and biotech leader, to its Board of Directors effective July 1, 2026. Ms. Gold brings financial, capital markets, and scientific expertise, and will serve as an independent director and Audit Committee member. The company continues to advance mavorixafor toward approval and commercialization for rare hematology diseases.

• · Kelly Gold serves as CFO of CAMP4 Therapeutics, a publicly traded biotech.
• · She previously held finance roles at Biogen and Deutsche Bank, and began her career as a mechanical engineer designing biocontainment systems for Biosafety Level 4 labs.
• · Ms. Gold holds bachelor’s degrees in Biochemistry and Mechanical Engineering from Queen’s University, and an MBA from MIT Sloan School of Management.
• · Mavorixafor is approved in the U.S. and EU as XOLREMDI for WHIM syndrome and has FDA Fast Track designation for chronic neutropenia.

01-07-2026

Rigel Pharmaceuticals announced the appointment of Alison L. Hannah, M.D. as Executive Vice President and Chief Medical Officer, effective July 1, 2026, replacing Lisa Rojkjaer, M.D., who separated from the company on June 25, 2026. Dr. Hannah resigned from the Board of Directors upon her appointment, having served as a director since May 2021. The filing does not disclose any financial terms or performance metrics, and no negative or flat performance data is present.

• · Dr. Hannah had served as a member of the Board since May 2021.
• · Prior to consulting, Dr. Hannah served as Chief Medical Officer of CytomX Therapeutics and as Senior Medical Director at SUGEN, Inc.
• · Lisa Rojkjaer, M.D. ceased serving as EVP and CMO effective June 25, 2026.

01-07-2026

BAB, Inc. elected George M. Ristau, Jr. to its Board of Directors on July 1, 2026, filling the vacancy caused by the passing of James A. Lentz. Mr. Ristau, a 74-year-old attorney and real estate broker with extensive legal and business experience, was also appointed to the Audit Committee. The filing contains no financial data or period-over-period comparisons.

• · Mr. Ristau will serve until the Company's 2027 Annual Meeting of Shareholders.
• · He graduated from DePaul University (1973) and Chicago-Kent College of Law (1976).
• · He has been Broker/Owner of Weichert, Realtors - All Pro, Inc. since 2000.
• · There are no arrangements or transactions requiring disclosure under Item 404(a).

01-07-2026

Michael Goettler has resigned from Bausch Health's Board of Directors effective June 30, 2026, due to his appointment as President and CEO of Knoa Pharma LLC. The resignation was not due to any disagreement with the company. This is a non-financial governance change with no material impact on operations.

• · Resignation effective June 30, 2026.
• · Goettler's new role is President and CEO of Knoa Pharma LLC.
• · No disagreement with Bausch Health's operations, policies, or practices led to the resignation.

01-07-2026

AMD announced base salary increases for its top five executives effective July 1, 2026, and approved new long-term incentive equity awards to be granted on August 15, 2026. CEO Lisa Su's base salary rises from $1,323,000 to $1,375,000, and her target equity award value is $36 million, with 75% tied to performance-based restricted stock units. The compensation changes reflect the board's ongoing alignment of executive pay with company performance, though the filing does not disclose any corresponding financial results or operational metrics.

• · PRSUs can be earned from 0% to 250% of target, but if AMD's TSR over the performance period (Aug 15, 2026 to Aug 15, 2029) is negative, earned PRSUs are capped at 100% of target.
• · Additional PRSUs (0%, 25%, or 50% of those earned under TSR) are tied to non-GAAP EPS growth from fiscal 2026 to fiscal 2028.
• · RSUs vest 1/4 on Aug 15, 2027, then quarterly through Aug 15, 2030.
• · Darren Grasby's salary is denominated in British pounds (£615,000 prior, £640,000 new) and converted to USD at $1.31854 per £1.

01-07-2026

Williams Companies appointed Billy Helms (former EOG Resources president) and Robb Turner (co-founder of ArcLight Capital Partners) as independent directors, effective July 1, 2026. The board now has 12 members, 11 of whom are independent. The appointments strengthen the board's operational and financial expertise as the company pursues its natural gas-focused growth strategy.

• · Helms has over 40 years of energy industry experience, including roles as president and COO of EOG Resources.
• · Turner has over 35 years of experience and co-founded ArcLight Capital Partners, which raised six funds and invested over $17 billion.
• · Turner previously served as chairman of Crowheart Energy prior to its sale to Williams.
• · Helms currently serves on the SM Energy Board and chairs its Operations and EHS Committee.
• · Turner holds a B.S. in engineering from West Point and an MBA from Harvard Business School.

01-07-2026

On July 1, 2026, FirstSun Capital Bancorp's board approved the Executive Annual Incentive Plan, which establishes a framework for cash incentive awards based on a broad set of financial and non-financial performance measures. The plan is administered by the Compensation Committee, which selects participants, sets threshold/target/maximum award levels, and may adjust payouts. No specific financial figures or performance targets were disclosed in this filing.

• · The plan includes over 30 potential performance measures covering asset quality, balance sheet growth, earnings, capital ratios, customer satisfaction, employee turnover, and share price.
• · Awards are generally forfeited if the participant is not employed on the payment date, except in cases of death, disability, retirement, or as otherwise approved.
• · The Compensation Committee has full authority to waive conditions, increase or decrease payouts, and interpret the plan.

01-07-2026

On June 30, 2026, High Roller Technologies, Inc. held its annual meeting of stockholders. Stockholders voted to elect all six director nominees, approved an amendment to the 2024 Equity Incentive Plan increasing the individual award limit from 170,000 to 250,000 shares, and ratified WithumSmith+Brown, PC as the independent auditor for fiscal 2026. All proposals received strong support from stockholders representing a 68.9% voter turnout (7,562,064 of 10,968,987 shares).

• · Stockholders approved the plan amendment with 6,312,420 for, 100,521 against, 3,767 abstain, and 1,145,356 broker non-votes.
• · Ratification of WithumSmith+Brown, PC received 7,473,420 for, 3,738 against, and 84,906 abstain (no broker non-votes).
• · The annual meeting was held on June 30, 2026, and the Form 8-K was filed on July 1, 2026.
• · The document includes an amendment to the 2024 Equity Incentive Plan as Exhibit 10.1.
• · The company is an emerging growth company and has not elected to use the extended transition period for complying with new financial accounting standards.

01-07-2026

American Eagle Outfitters (AEO) announced that CFO Mike Mathias will transition to a non-executive strategic advisor role effective August 3, 2026, after 25 years of service, and will be succeeded by Ravi Thanawala, former CFO of Papa John's and Nike North America. The company reaffirmed its Q2 and full-year fiscal 2026 guidance, signaling stable near-term expectations despite the leadership change.

• · Mathias will serve as a full-time non-executive strategic advisor to Jay Schottenstein effective August 3, 2026.
• · Thanawala previously served as CFO and President, North America of Papa John's (Nov 2025), CFO and EVP, International (Sep 2024), and Interim CEO (Mar-Aug 2024).
• · Thanawala was CFO of Nike North America from June 2020 to July 2023 and Global VP/CFO of Converse from 2018 to 2020.
• · AEO reaffirmed its Q2 and full-year fiscal 2026 guidance as announced on May 28, 2026.
• · Mathias will continue supporting Schottenstein through July 30, 2027.

01-07-2026

Six Flags Entertainment Corporation amended the employment agreement of COO Tim Fisher, setting his term to expire on December 15, 2026, and extending certain benefits through that date to retain him. However, Mr. Fisher agreed to forgo his 2026 annual equity grant and retention bonus, indicating a cost-saving measure or a transitional arrangement.

• · The amendment was entered into on June 25, 2026, and the 8-K was filed on July 1, 2026.
• · Mr. Fisher will not receive a 2026 annual equity grant or retention bonus payment under the amended agreement.

01-07-2026

Aon plc filed an 8-K reporting the extension of CEO Gregory C. Case's international assignment letter to June 30, 2027, and the results of its 2026 Annual Meeting. Notably, shareholders did not approve the advisory vote on executive compensation (Say-on-Pay), with 110.8 million votes against versus 69.9 million for. Additionally, the Board authorized a $7.5 billion increase to the share repurchase program, supplementing the remaining $0.8 billion authorization.

• · The advisory vote on executive compensation (Say-on-Pay) was not approved: 69,888,299 for, 110,798,636 against, 1,112,848 abstain.
• · All 13 director nominees were elected, with the highest 'against' votes for Lester B. Knight (15,620,855) and Richard C. Notebaert (14,215,327).
• · Shareholders approved the ratification of Ernst & Young LLP as independent auditor (174,935,923 for, 19,452,290 against).
• · Shareholders approved the re-appointment of Ernst & Young Chartered Accountants as statutory auditor (178,371,633 for, 16,018,978 against).
• · Shareholders authorized the Board to issue Class A Ordinary Shares under Irish law for 18 months (189,746,449 for, 4,618,161 against).
• · Shareholders authorized the Board to opt-out of statutory pre-emption rights under Irish law for 18 months (182,606,169 for, 11,750,382 against).
• · The share repurchase program increase of $7.5B is in addition to the existing $0.8B remaining authorization.

01-07-2026

Ambarella held its 2026 Annual Meeting on June 26, 2026, with 86.31% of outstanding shares represented. Shareholders approved the election of three Class II directors (Gregory M. Bryant, D. Jeffrey Richardson, Elizabeth M. Schwarting), ratified the appointment of PricewaterhouseCoopers as independent auditor, approved executive compensation on a non-binding advisory basis, and approved the amended Ambarella 2021 Equity Incentive Plan. However, support for the equity plan was notably split, with 22.1 million shares in favor and 10.5 million against, representing only 67.8% approval among votes cast (excluding broker non-votes).

• · The Amended and Restated 2021 Plan was approved but with significant shareholder dissent: 22,122,462 For, 10,481,483 Against, and 53,190 Abstentions.
• · Director Elizabeth M. Schwarting received the most withheld votes (6,395,405, or ~19.6% of votes cast), followed by D. Jeffrey Richardson (3,594,265 withheld).
• · Director Gregory M. Bryant received near-unanimous support, with only 211,504 votes withheld.
• · Ratification of PwC as independent auditor passed overwhelmingly: 37,426,967 For, 407,966 Against, 21,379 Abstentions.
• · Advisory vote on executive compensation passed with 30,602,569 For, 1,984,036 Against, 70,530 Abstentions (93.9% approval among votes cast).
• · The company has 43,861,484 ordinary shares outstanding, par value $0.00045 per share, trading on Nasdaq as AMBA.

01-07-2026

Allbirds, Inc. (BIRD) disclosed that board member Ravi Thanawala resigned effective July 14, 2026, to become CFO of American Eagle Outfitters. The resignation was not due to any disagreement with the company. No financial impact or performance data was provided.

• · Resignation effective July 14, 2026, to allow orderly transition.
• · Mr. Thanawala is leaving to assume the CFO role at American Eagle Outfitters, Inc.
• · No disagreement with Allbirds' operations, policies, or practices was cited.

01-07-2026

Reinsurance Group of America (RGA) appointed Maurice Tulloch to its Board of Directors, effective July 1, 2026. Tulloch is the former CEO of Aviva Group and brings extensive international insurance and governance experience. The appointment is a routine board addition with no immediate financial impact.

• · Maurice Tulloch holds a Chartered Professional Accountant (CPA) designation, an MBA from Heriot-Watt University, and a B.A. in Economics from the University of Waterloo.
• · Tulloch previously served on the boards of Aviva plc, The Geneva Association, the Insurance Development Forum, ClimateWise, and the Insurance Bureau of Canada.
• · RGA was founded in 1973 and is one of the world's largest life and health reinsurers.

01-07-2026

Enterprise Products Partners L.P. (EPD) announced that co-CEO A.J. 'Jim' Teague will retire on January 4, 2027, with co-CEO W. Randall 'Randy' Fowler succeeding him as sole CEO. The company highlighted Teague's 28-year tenure, during which enterprise value grew from $1.8 billion to nearly $120 billion, and noted that the Office of the Chairman will expand to include the CFO and CCO upon his retirement. The transition appears orderly and well-planned, with no negative financial metrics reported.

• · Jim Teague joined Enterprise in 1999 and has 28 years with the company; prior to that he spent 22 years at Dow Chemical.
• · Randy Fowler has served as a director since 2011, co-CEO since 2020, and CFO from 2007-2015 and 2018-2024; he has 48 years of finance and accounting experience.
• · Upon Teague's retirement, the Office of the Chairman will expand to include the CFO and CCO.
• · Enterprise's assets include over 50,000 miles of pipelines, over 300 million barrels of storage capacity, and 14 billion cubic feet of natural gas storage.
• · The company became the first midstream company to provide wellhead-to-water NGL services in 2009.

01-07-2026

McKesson Corporation announced the retirement of Thomas L. Rodgers, Executive Vice President, Chief Strategy and Business Development Officer, effective August 1, 2026. To ensure an orderly transition, Ramesh Srinivasan has been appointed as Executive Vice President, Chief Strategy Officer, effective the same date. The filing does not include any financial results or performance metrics.

• · Thomas L. Rodgers' last day of employment is August 1, 2026.
• · Ramesh Srinivasan's appointment as Executive Vice President, Chief Strategy Officer is effective August 1, 2026.
• · The filing was signed by Michele Lau, Executive Vice President and Chief Legal Officer.

01-07-2026

CPI Card Group Inc. announced the permanent appointment of Terra Grantham as Chief Financial Officer, effective immediately, after she served as Interim CFO since February 2026. Grantham, a 9-year CPI veteran and former Senior Vice President of Enterprise Strategy and Growth, will lead the finance organization and continue driving the company's digital transformation and capital allocation strategy.

• · Grantham holds a BA in Economics from Grinnell College and an MBA from the University of Michigan.
• · Prior to CPI, she held leadership positions at Western Union and Unilever.
• · Grantham has been with CPI since 2017, over nine years.
• · The appointment is effective immediately as of July 1, 2026.

01-07-2026

Casella Waste Systems appointed Damian A. Ribar as Executive Vice President and Chief Operating Officer, effective July 20, 2026. Mr. Ribar brings extensive industry experience from Waste Connections and other waste services companies. His compensation package includes a $500,000 base salary, up to 85% cash bonus, and equity awards totaling $800,000 annually, plus a one-time stock option for 25,000 shares.

• · Mr. Ribar previously served as Division Vice President of North Florida of Waste Connections from August 2025 to July 2026.
• · He holds a Bachelor of Science in Accounting from University of Pittsburgh at Johnstown.
• · No family relationships or reportable transactions involving Mr. Ribar.
• · Relocation expenses will be reimbursed, subject to full repayment if he voluntarily leaves within 2 years.
• · Temporary transitional housing provided for up to 12 weeks.

01-07-2026

Omnicell appointed Nnamdi Njoku as President, effective July 1, 2026, while he retains his role as COO. Randall Lipps continues as CEO and Chairman, focusing on strategic collaborations and long-term solution evolution. The appointment reflects a leadership evolution with no financial metrics disclosed.

• · Njoku holds an MBA from Cornell University and a BA in Business Administration from the University of St. Thomas.
• · He is a Fellow of the fourth class of Aspen Institute’s Health Innovators Fellowship and a member of the Aspen Global Leadership Network.
• · Prior to Omnicell, Njoku served as SVP and President of Medtronic's Neuromodulation Operating Unit, an approximately $2 billion business.

01-07-2026

Prologis appointed Alfred F. Kelly, Jr., former CEO of Visa Inc., to its board of directors effective July 1, 2026. Kelly brings extensive experience in technology, risk, and global markets from his leadership roles at Visa and American Express. The appointment strengthens the board's expertise as Prologis continues to evolve its logistics infrastructure business.

• · Kelly served as CEO of Visa from 2016 to 2023 and as executive chairman until 2024.
• · He currently serves on the board of General Motors Company, including its Audit and Risk & Cybersecurity Committees.
• · Since 2024, Kelly has been an Advisory Director at Berkshire Partners.
• · He holds a BA in Computer Science and an MBA from Iona University.

01-07-2026

REX American Resources Corporation entered into new employment agreements with Executive Chairman Stuart A. Rose, CEO Zafar A. Rizvi, and CFO Douglas L. Bruggeman, effective February 1, 2026, and executed on June 29, 2026. The agreements significantly increase annual maximum bonus limits—for Rose from $2.5M to $4M, for Rizvi from $5M to $12M, and for Bruggeman from $2.5M to $4M—and raise termination-related bonus caps. Base salaries remain modest at $225,000 (Rose), $275,000 (Rizvi), and $300,000 (Bruggeman), with bonuses tied to company earnings.

• · Employment agreements are with REX Management, Inc., an indirect wholly-owned subsidiary of REX American Resources Corporation.
• · The agreements supersede prior employment agreements (most recently the 2022 Agreement for Rose).
• · Each agreement includes a one-year term (February 1, 2026 to January 31, 2027) with automatic renewal unless 180-day notice of termination is given.
• · Bonuses are computed based on company earnings; specific formula not disclosed.
• · Termination provisions include: without cause (salary balance + bonus + accelerated equity), for cause (pro-rata salary and bonus), death/disability/voluntary (pro-rata salary and bonus, plus equity exercise rights if 20 years service and age 55 for voluntary), and change-in-control with good reason (salary balance + bonus + accelerated equity).
• · Post-termination restrictions include one-year non-compete and confidentiality covenants.
• · The Compensation Committee engaged Pearl Meyer in December 2025 to assess compensation and recommend market-based adjustments.

01-07-2026

Bloomin' Brands, Inc. announced the resignation of Jessica Mitory as Senior Vice President and Chief Human Resources Officer, effective August 17, 2026. The departure is not related to any disagreement with the company regarding operations, policies, or practices. No financial impact or performance metrics were disclosed in this filing.

• · Resignation notice date: June 26, 2026
• · Effective departure date: August 17, 2026
• · No disagreement with company operations, policies, or practices cited as reason for departure
• · Filing date: July 1, 2026

01-07-2026

Tecogen Inc. granted equity awards and salary increases to its CEO and named executive officers to align their interests with stockholders. CEO Abinand Rangesh received 174,081 restricted shares and 26,041 incentive stock options, along with a 5% base salary increase to $220,500. Other executives received smaller equity grants and 3% salary increases, reflecting a balanced but modest compensation adjustment.

• · All equity awards vest in equal installments on the first, second, third, and fourth anniversaries of the grant date.
• · Incentive stock options are exercisable at a price of $5.17 per share.
• · The Compensation Committee recommended and the Board approved the awards and salary increases on June 26, 2026.

01-07-2026

FG Nexus Inc. announced plans to establish a new real estate division focused on land-lease manufactured housing and to exit its digital asset business, reallocating capital to tangible assets. In connection with this strategic shift, Maja Vujinovic, Co-Founder and CEO of the Digital Assets Division, will step down from her role and the Board, remaining as a strategic consultant. The company also continues to advance a potential combination with FG Communities, Inc. to expand into income-producing affordable housing.

• · Maja Vujinovic has been building in digital assets since 2011 and in artificial intelligence since 2016.
• · The company intends to reallocate all capital from digital assets to cash flow producing real estate over the near term.
• · The company has identified a solid pipeline of target properties to begin acquiring.
• · The company is a merchant bank and real estate focused operating company.

01-07-2026

ModuLink Inc. (OTC: MDLK) announced the appointment of Dr. Wah Shing Lam, age 31, as an Executive Director effective July 1, 2026. Dr. Lam will continue in his role as Chief Technology Officer, overseeing technology strategy, R&D, and AI/robotics/automation integration. The filing contains no financial data or period-over-period comparisons, making materiality low.

• · Dr. Lam's appointment was approved by the Board based on his experience, expertise, leadership, and contributions.
• · Dr. Lam will remain CTO and oversee technology strategy, R&D, and integration of AI, robotics, and automation.
• · ModuLink focuses on MiC, A2W technology, IoT property management, AI robotics, and intelligent healthcare solutions.

01-07-2026

Choice Hotels International appointed Ali Keshavarz, President and Chief Data & Analytics Officer of CVS Health, to its Board of Directors as an independent director. Keshavarz brings deep expertise in artificial intelligence and advanced analytics, which the company expects to strengthen its long-term growth strategy and create value for franchise owners, guests, and shareholders. The filing does not include any financial results or period-over-period comparisons.

• · Ali Keshavarz holds an M.B.A. from Columbia Business School and a B.A. in mathematics and economics from Northwestern University.
• · He previously served as Chief Analytics Officer for Aetna and CVS Caremark.
• · Before CVS Health, he spent over a decade at McKinsey, co-founding the firm's healthcare analytics practice.
• · Choice Hotels has over 7,500 hotels representing more than 650,000 rooms in 51 countries and territories.
• · The company's portfolio includes 22 brands spanning full-service upper upscale, midscale, extended stay, and economy properties.

01-07-2026

Inogen announced the appointment of Andy Reding to the newly created role of Chief Operating Officer, effective July 6, 2026. Mr. Reding brings over 30 years of leadership experience in medical technology and respiratory care, and will receive an inducement equity award of 130,000 RSUs vesting over three years. The appointment aims to strengthen leadership structure to support global commercial and operational execution, though no specific financial metrics or prior performance comparisons were provided in the filing.

• · Andy Reding previously served as Chief Commercial Officer of Viant Medical for over six years, leading teams across 25 facilities serving top medical device companies.
• · Reding has extensive respiratory care experience as Vice President and General Manager of Hillrom Respiratory Health, where he led sales, marketing, R&D, reimbursement, and third-party billing.
• · The RSU award was approved under Nasdaq Listing Rule 5635(c)(4) as an inducement grant.
• · Inogen intends to use its Investor Relations website for disclosing material non-public information under Regulation FD.

01-07-2026

SeaStar Medical Holding Corp approved retention bonuses totaling $340,000 for CEO Eric Schlorff ($200,000) and Kevin Chung ($140,000), payable in three installments through March 2027, with an additional 25% of each payment in restricted stock. The bonuses are part of a broader retention program for long-serving employees, but the filing does not disclose any financial performance metrics or operational updates.

• · Retention bonuses vest in three installments: July 1, 2026, November 1, 2026, and March 1, 2027.
• · If an executive departs before a vesting date, no future payments are made; if separated without cause, a pro-rata amount is paid.
• · The restricted stock component is issued under the Company's 2022 Omnibus Incentive Plan, with share count based on closing price on each vesting date.
• · The program also covers additional long-serving Company employees beyond the named executives.